• SENSEX 73,055.43
    -193.96 (--0.26%)
  • BANKNIFTY 54,925.70
    -51.20 (--0.09%)
  • SBI
    950.75 900.80(%)
  • Cyient
    1,268.00 1,226.25(%)
  • NSE
    1,640.25 1,683.00(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 970.70(%)
  • Eternal
    317.50 344.75(%)
  • IndusInd Bank
    832.00 750.45(%)
  • Persistent Systems
    5,909.85 6,597.00(%)
  • Swiggy
    174.90 207.75(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,015.20(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Divi's Lab.
    8,800.00 5,648.00(%)
  • PC Jeweller
    17.08 7.45(%)
  • Steel Str. Wheel
    469.70 434.05(%)
  • Reliance Industries
    1,201.95 1,611.20(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lincoln Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 12683.0
  • ISIN : INE405C01035
510.85 -4 (-0.72%)
  • As on 23 Oct 2026 (EOD)

  • Today’s Low

    503.35

  • Today’s High

    529.55

  • Open

    514.55

  • Perv Close

    514.55

  • 52W Low

    440.00

  • 52W High

    770.00

Key Indicators

  • P/E(TTM)

    10.63

  • Mar.Cap (₹Cr.)

    1,023.22

  • Div & Yield %

    0.00

  • Book Value(₹)

    378.25

  • Debt-Equity Ratio

    -0.72

  • AGM Date

    22-Oct-2026

  • EPS

    48.15

  • P/E Ratio

    10.63

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    1,023.22

  • RONW (%)

    17.04

  • ROCE (%)

    22.35

Score Board

  • Equity (₹ in Cr.)

    20.03

  • BV (₹)

    378.30

  • Sales( ₹ in Cr.)

    671.03

  • NP (in Cr.)

    85.68

  • NP Var(%)

    7.0

  • Div%

    0.0

  • CPS (₹)

    50.00

  • EPS (₹)

    42.80

  • Traded Value (₹ in Lakhs)

    1,025.52

  • 52 Week High

    770.00

  • 52 Week Low

    440.00

  • Price BSE

    512.0

  • Price NSE

    511.00

  • Market Capital( in Cr.)

    1,025.52

  • P/C Ratio

    10.20

  • P/E Ratio

    12.00

  • Price Vs.BV

    42.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 671.03 623.23 580.55 510.31 472.08 422.91
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 671.03 623.23 580.55 510.31 472.08 422.91
Other Income 33.45 22.48 34.42 22.48 10.00 5.74
Stock Adjustments 7.44 -8.84 5.70 4.24 13.57 -3.67
Total Income 711.92 636.87 620.67 537.03 495.65 424.98
EXPENDITURE :            
Raw Materials 318.60 282.48 284.04 245.64 232.15 193.26
Power and Fuel Cost 11.10 11.66 11.47 10.25 8.33 7.10
Employee Cost 125.19 112.45 102.90 93.16 79.72 63.20
Other Manufacturing Expenses 31.02 27.93 23.70 19.55 16.61 16.27
Selling and Administration Expenses 90.62 75.28 60.99 54.50 50.88 50.80
Miscellaneous Expenses 4.26 3.10 3.24 2.28 2.50 1.58
Employee Benefit Expenses 125.19 112.45 102.90 93.16 79.72 63.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 580.79 512.90 486.34 425.39 390.18 332.20
Operating Profit 131.13 123.97 134.33 111.65 105.47 92.78
Interest 1.01 1.88 1.46 2.03 1.45 1.55
Gross Profit 130.12 122.09 132.87 109.62 104.02 91.23
Depreciation 14.50 12.90 10.62 9.17 8.09 7.56
Profit Before Tax 115.62 109.19 122.25 100.45 95.93 83.67
Current Tax 27.76 25.33 25.44 25.97 25.85 21.17
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.03 1.52 3.49 1.59 0.72 0.25
Reported Net Profit 87.89 82.35 93.30 72.90 69.35 62.25
Extraordinary Items 2.21 2.15 1.07 0.37 0.61 -0.09
Adjusted Net Profit 85.68 80.20 92.23 72.53 68.74 62.34
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 585.70 507.46 417.66 348.26 282.41 220.66
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.11 4.11 3.50 3.50 3.50 0.50
P & L Balance carried down 669.49 585.70 507.46 417.66 348.26 282.41
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 18.00 18.00 15.00 15.00 15.00
Dividend Per Share(Rs) 1.80 1.80 1.80 1.50 1.50 1.50
Earnings Per Share-Unit Curr 43.88 41.11 46.58 36.40 34.63 31.08
Earnings Per Share(Adj)-Unit Curr 43.88 41.11 46.58 36.40 34.63 31.08
Book Value 378.25 335.34 295.98 250.86 216.12 182.92
Book Value(Adj)-Unit Curr 378.25 335.34 295.98 250.86 216.12 182.92

Shareholding Pattern

  • Promoter Group

    49.78%

  • Public Share Holding

    50.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,081,000 5.40 1,081,000 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,888,930 44.38 8,888,930 22
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,969,930 49.78 9,969,930 25
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 912,218 4.55 912,218 48
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 394 0.00 394 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,568 0.02 3,568 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 916,180 4.57 916,180 52
2] Non Institution
Bodies Corporate 224,574 1.12 224,574 136
Clearing Members 14,251 0.07 14,251 18
Directors of their Relatives 478,400 2.39 478,400 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 480,534 2.40 480,534 659
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 569,326 2.84 569,326 617
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,361,483 11.79 2,361,483 39
Individuals holding nominal share capital up to Rs. 1 lakh 4,945,063 24.69 4,856,339 27,715
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 59,684 0.30 59,684 3
Sub Total 9,143,618 45.65 9,054,894 29,195
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 20,029,728 100.00 19,941,004 29,272

Company Background

Lincoln Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Lincoln Pharmaceuticals Ltd
  • BSE Code : 12683.0
  • ISIN : INE405C01035

  • Incorporation Year

    1995

  • Registered Office

    Lincoln House B/H Satyam Compe
    Science City Road Sola, Ahmedabad,
    Gujarat-380060

  • Telephone

    91-079-67778000

  • FAX

    91-079-67778062

  • Chairman

    Kishorbhai M Shah

  • Managing Director

    Mahendra G Patel

  • Company Secretary

    Trusha Shah

  • Auditor

    Samir M Shah & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Lincoln Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lincoln Pharma. 512.00 704.48 671.03 10.63 16.11
Abbott India 25,393.50 7,217.19 6,929.05 33.42 43.78
Astrazeneca Phar 6,098.65 2,304.07 2,275.58 89.88 27.86
Glaxosmi. Pharma 2,434.70 3,932.76 3,790.20 38.89 58.17
Novartis India 1,686.70 393.10 354.33 42.59 15.94
Cipla 1,329.90 20,102.60 18,979.95 34.95 13.88
Bliss GVS Pharma 640.25 773.53 729.81 59.50 12.51
Amrutanjan Healt 495.80 520.13 502.55 26.56 24.16
Fermenta Biotec. 457.40 474.15 450.25 21.35 18.77
Guj. Themis Bio. 355.10 168.25 165.82 94.95 18.05
Ambalal Sarabhai 36.28 19.52 3.94 67.19 6.77